Document is current
Any future updates will be listed below
-
Authors
Civil, Yasmin A.
Oei, Arlene L.
Duvivier, Katya M.
Bijker, Nina
Meijnen, Philip
Donkers, Lorraine
Verheijen, Sonja
van Kesteren, Zdenko
Palacios, Miguel A.
Schijf, Laura J.
Barbé, Ellis
Konings, Inge R. H. M.
-van der Houven van Oordt, C. Willemien Menke
Westhoff, Paulien G.
Meijer, Hanneke J. M.
Diepenhorst, Gwen M. P.
Thijssen, Victor
Mouliere, Florent
Slotman, Berend J.
van der Velde, Susanne
van den Bongard, H. J. G. Desirée
- License Information
-
More Information
Article History
Received: 23 January 2023
Accepted: 3 May 2023
First Online: 9 May 2023
Declarations
:
: Ethical committee approval of the Amsterdam University Medical Centre, location Vrije Universiteit Medical Centre (reference number NL77000.029.21) was obtained for the ABLATIVE-2 study. The study has been approved by the institutional review board of Amsterdam University Medical Centre. The study has also been approved by the institutional review board of Radboud University Medical Centre in Nijmegen. All methods are carried out in accordance with relevant guidelines and regulations. All participants will sign an informed consent. Informed consent was also required from a healthy volunteer who agreed to use the MRI-image for creating radiotherapy treatment plans and for publication.
: Consent was obtained from the healthy volunteer to use the MR-image for publication.
: The authors declare no competing interests.
